PTC THERAPEUTICS MP INC has a total of 17 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), Australia and Brazil. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are NAVITOR PHARMACEUTICALS INC, KALYRA PHARMACEUTICALS INC and BIOPHYSICA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | Brazil | 3 | |
#4 | Canada | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Colombia | 1 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Smith Neil | 10 |
#2 | Reis Jonathan | 9 |
#3 | Levy Daniel E | 6 |
#4 | Shiro Yuichi | 4 |
#5 | Kishimoto Kaito | 4 |
#6 | Komoda Taichi | 4 |
#7 | Murata Shunichi | 4 |
#8 | Yoshino Hiroshi | 4 |
#9 | Matsumoto Takayoshi | 4 |
#10 | Jonathan Reis | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021062264A1 | Methods for treating hyperphenylalaninemia | |
WO2021026247A1 | Use of sepiapterin and metabolites thereof to treat radiation exposure | |
BR112020024332A2 | pharmaceutically acceptable salts of sepiapterin | |
BR112020024346A2 | methods to increase plasma sepiapterin exposure | |
AU2019277382A1 | Methods for increasing sepiapterin plasma exposure |